BetaGlue Therapeutics’ Post

BetaGlue's CEO Colin Story and Head of Clinical Development Gianluca De Danieli MD PhD MSc are in Miami at the SPECTRUM 2025 Conference sharing updates on the development of YntraDose with clinical KOL's and thought leaders in Interventional Radiology. Our thanks to Prof. Govindarajan Narayanan for leading and organising this conference and to Prof Roberto Iezzi, MD, fCIRSE for presenting BetaGlue's latest data. We'll be catching up with our other esteemed Clinical Advisory Board members Jafar Golzarian and Luigi Solbiati. #betaglue #radiotherapy #innovation

  • graphical user interface

To view or add a comment, sign in

Explore topics